DNA Vaccination with the Hantaan Virus M Gene Protects Hamsters Against Three of Four HFRS Hantaviruses and Elicits a High-titer Neutralizing Antibody Response in Rhesus Monkeys

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2001 Aug 17

PMID 11507192

Citations 53

Authors

J W Hooper

D M Custer

E Thompson

C S Schmaljohn

Affiliations

Soon will be listed here.

Abstract

Four hantaviruses-Hantaan virus (HTNV), Seoul virus (SEOV), Dobrava virus (DOBV) and Puumala virus-are known to cause hemorrhagic fever with renal syndrome (HFRS) in Europe and Asia. HTNV causes the most severe form of HFRS (5 to 15% case-fatality rate) and afflicts tens of thousands of people annually. Previously, we demonstrated that DNA vaccination with a plasmid expressing the SEOV M gene elicited neutralizing antibodies and protected hamsters against infection with SEOV and HTNV. Here, we report the construction and evaluation of a DNA vaccine that expresses the HTNV M gene products, G1 and G2. DNA vaccination of hamsters with the HTNV M gene conferred sterile protection against infection with HTNV, SEOV, and DOBV. DNA vaccination of rhesus monkeys with either the SEOV or HTNV M gene elicited high levels of neutralizing antibodies. These are the first immunogenicity data for hantavirus DNA vaccines in nonhuman primates. Because a neutralizing antibody response is considered a surrogate marker for protective immunity in humans, our protection data in hamsters combined with the immunogenicity data in monkeys suggest that hantavirus M gene-based DNA vaccines could protect humans against the most severe forms of HFRS.

Citing Articles

Achievement and Challenges in Orthohantavirus Vaccines.

Chai S, Wang L, Du H, Jiang H Vaccines (Basel). 2025; 13(2).

PMID: 40006744 PMC: 11861054. DOI: 10.3390/vaccines13020198.

Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injection.

Hooper J, Kwilas S, Josleyn M, Norris S, Hutter J, Hamer M NPJ Vaccines. 2024; 9(1):221.

PMID: 39551791 PMC: 11570633. DOI: 10.1038/s41541-024-00998-7.

Comparison of uridine and N1-methylpseudouridine mRNA platforms in development of an Andes virus vaccine.

Kuzmin I, Soto Acosta R, Pruitt L, Wasdin P, Kedarinath K, Hernandez K Nat Commun. 2024; 15(1):6421.

PMID: 39080316 PMC: 11289437. DOI: 10.1038/s41467-024-50774-3.

Single dose recombinant VSV based vaccine elicits robust and durable neutralizing antibody against Hantaan virus.

Zhang H, Liu H, Wei J, Dang Y, Wang Y, Yang Q NPJ Vaccines. 2024; 9(1):28.

PMID: 38341504 PMC: 10858903. DOI: 10.1038/s41541-024-00814-2.

Corrigendum: Hantavirus: an overview and advancements in therapeutic approaches for infection.

Afzal S, Ali L, Batool A, Afzal M, Kanwal N, Hassan M Front Microbiol. 2023; 14:1343080.

PMID: 38149269 PMC: 10750826. DOI: 10.3389/fmicb.2023.1343080.

References

Chu Y, Jennings G, Schmaljohn C . A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus. J Virol. 1995; 69(10):6417-23. PMC: 189541. DOI: 10.1128/JVI.69.10.6417-6423.1995. View

Zhu Z, Tang H, Li Y, Weng J, Yu Y, Zeng R . Investigation on inactivated epidemic hemorrhagic fever tissue culture vaccine in humans. Chin Med J (Engl). 1994; 107(3):167-70. View

Elgh F, Lundkvist A, Alexeyev O, Stenlund H, Avsic-Zupanc T, Hjelle B . Serological diagnosis of hantavirus infections by an enzyme-linked immunosorbent assay based on detection of immunoglobulin G and M responses to recombinant nucleocapsid proteins of five viral serotypes. J Clin Microbiol. 1997; 35(5):1122-30. PMC: 232715. DOI: 10.1128/jcm.35.5.1122-1130.1997. View

Schmaljohn C, Hjelle B . Hantaviruses: a global disease problem. Emerg Infect Dis. 1997; 3(2):95-104. PMC: 2627612. DOI: 10.3201/eid0302.970202. View

Lundkvist A, Hukic M, Horling J, Gilljam M, Nichol S, Niklasson B . Puumala and Dobrava viruses cause hemorrhagic fever with renal syndrome in Bosnia-Herzegovina: evidence of highly cross-neutralizing antibody responses in early patient sera. J Med Virol. 1997; 53(1):51-9. View

Schmaljohn C, VanderZanden L, Bray M, Custer D, Meyer B, Li D . Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge. J Virol. 1997; 71(12):9563-9. PMC: 230264. DOI: 10.1128/JVI.71.12.9563-9569.1997. View

Hooper J, Kamrud K, Elgh F, Custer D, Schmaljohn C . DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection. Virology. 1999; 255(2):269-78. DOI: 10.1006/viro.1998.9586. View

Peters C, Simpson G, Levy H . Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu Rev Med. 1999; 50:531-45. DOI: 10.1146/annurev.med.50.1.531. View

Bharadwaj M, Lyons C, Wortman I, Hjelle B . Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice. Vaccine. 1999; 17(22):2836-43. DOI: 10.1016/s0264-410x(99)00096-1. View

10.

Kamrud K, Hooper J, Elgh F, Schmaljohn C . Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters. Virology. 1999; 263(1):209-19. DOI: 10.1006/viro.1999.9961. View

11.

Chen H, Pan C, Liau M, Jou R, Tsai C, Wu H . Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. J Virol. 1999; 73(12):10137-45. PMC: 113066. DOI: 10.1128/JVI.73.12.10137-10145.1999. View

12.

McClain D, Summers P, Harrison S, Schmaljohn A, Schmaljohn C . Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine. J Med Virol. 1999; 60(1):77-85. DOI: 10.1002/(sici)1096-9071(200001)60:1<77::aid-jmv13>3.0.co;2-s. View

13.

Lee H, Lee P, Johnson K . Isolation of the etiologic agent of Korean Hemorrhagic fever. J Infect Dis. 1978; 137(3):298-308. DOI: 10.1093/infdis/137.3.298. View

14.

Kitamura T, Morita C, Komatsu T, Sugiyama K, Arikawa J, Shiga S . Isolation of virus causing hemorrhagic fever with renal syndrome (HFRS) through a cell culture system. Jpn J Med Sci Biol. 1983; 36(1):17-25. DOI: 10.7883/yoken1952.36.17. View

15.

Tkachenko E, Bashkirtsev V, van der Groen G, Dzagurova T, Ivanov A, Ryltseva E . Isolation in Vero-E6 cells of Hanta virus from Clethrionomys glareolus captured in the Bashkiria area of the U.S.S.R. Ann Soc Belg Med Trop. 1984; 64(4):425-6. View

16.

Lee P, Gibbs Jr C, Gajdusek D, Yanagihara R . Serotypic classification of hantaviruses by indirect immunofluorescent antibody and plaque reduction neutralization tests. J Clin Microbiol. 1985; 22(6):940-4. PMC: 271855. DOI: 10.1128/jcm.22.6.940-944.1985. View

17.

Dantas Jr J, Okuno Y, Asada H, Tamura M, Takahashi M, Tanishita O . Characterization of glycoproteins of viruses causing hemorrhagic fever with renal syndrome (HFRS) using monoclonal antibodies. Virology. 1986; 151(2):379-84. DOI: 10.1016/0042-6822(86)90058-9. View

18.

Arikawa J, Schmaljohn A, Dalrymple J, Schmaljohn C . Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies. J Gen Virol. 1989; 70 ( Pt 3):615-24. DOI: 10.1099/0022-1317-70-3-615. View

19.

Asada H, Balachandra K, Tamura M, Kondo K, Yamanishi K . Cross-reactive immunity among different serotypes of virus causing haemorrhagic fever with renal syndrome. J Gen Virol. 1989; 70 ( Pt 4):819-25. DOI: 10.1099/0022-1317-70-4-819. View

20.

Zhang X, Takashima I, Hashimoto N . Characteristics of passive immunity against hantavirus infection in rats. Arch Virol. 1989; 105(3-4):235-46. DOI: 10.1007/BF01311360. View